InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Rouan Sarah Kathryn, Director. Officer active across 2 companies, notably Navidea Biopharmaceuticals, INC.. Cumulatively, 7 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €55k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 31 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
1,240 shares@ US$24.14745.2% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-25-052255:0
Ideal exit: 26 Dec 2025 (T+270)
1,240 shares@ US$24.14745.2% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-25-049717:0
Ideal exit: 26 Dec 2025 (T+270)
11,000 shares@ US$4.889.4% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-117514:0
25,000 shares@ US$8.3236.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-003008:0
30,000 shares@ US$8.3243.5% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-001973:0
4,892 shares0Common StockSEC:0001437749-21-016598
4,892 shares0Common StockSEC:0001437749-21-016598:0
7 of 7 declarations
About Rouan Sarah Kathryn
Sarah Kathryn Rouan is a Board Member at Navidea Biopharmaceuticals, Inc. She contributes to the governance of the company by bringing her expertise to the board. Her role involves overseeing operations and ensuring compliance with regulations. With her experience, she plays a vital role in strategic decision-making.
